share_log

Guggenheim Downgrades Q32 Bio to Neutral

Benzinga ·  Dec 12, 2024 23:14

Guggenheim analyst Yatin Suneja downgrades Q32 Bio (NASDAQ:QTTB) from Buy to Neutral.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment